![H. Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 212 458 $ al 30/09/2026
Ms. H.
S.
Parker is an Independent Director at Codexis, Inc., a Chairman at Sangamo Therapeutics, Inc. and a Principal at Parker Bioconsulting.
She is on the Board of Directors at Codexis, Inc. and Global Partnerships.
Ms. Parker was previously employed as an Independent Director by Armata Pharmaceuticals, Inc., an Independent Director by Impel Pharmaceuticals, Inc., a Chief Executive Officer & Director by Infectious Disease Research Institute, an Independent Director by OncoGenex Pharmaceuticals, Inc., an Independent Director by Achieve Life Sciences, Inc., a Chief Executive Officer & Director by Targeted Genetics Corp., a President & Director by Receptech Corp., a President, Chief Executive Officer & Director by Immunex Corp., and a Chairman by C3 Jian LLC.
She also served on the board at Inventprise, Inc., StrideBio, Inc., Nexgenia, Inc., Neose Technologies, Inc., Biotechnology Innovation Organization, OncoGenex Technologies, Inc. and Regence BlueShield.
She received her undergraduate degree from the University of Washington and an MBA from the University of Washington.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CODEXIS, INC. 0,13 % | 17/06/2026 | 143.583 ( 0,13 % ) | 199 580 $ | 30/09/2026 |
| 20/04/2026 | 87.600 ( 0,02 % ) | 12 877 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Presidente | 01/06/2017 |
| CODEXIS, INC. | Director/Miembro de la Junta | 16/12/2022 |
Global Partnerships
 Global Partnerships Financial ConglomeratesFinance Invests in partnerships with local organizations that use market-based solutions for people living in poverty | Director/Miembro de la Junta | - |
Parker Bioconsulting | Corporate Officer/Principal | 01/01/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
Inventprise LLC
 Inventprise LLC Pharmaceuticals: MajorHealth Technology Manufactures vaccines | Director/Miembro de la Junta | 01/04/2025 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Director/Miembro de la Junta | 01/12/2023 |
| IPI LEGACY LIQUIDATION CO | Director/Miembro de la Junta | 10/04/2023 |
| ACHIEVE LIFE SCIENCES, INC. | Director/Miembro de la Junta | 11/05/2021 |
| ARMATA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 08/12/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 21 |
|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Manufactures, markets, and researches therapeutic products | Health Technology |
Receptech Corp.
 Receptech Corp. Medical DistributorsDistribution Services Sells Immunex products | Distribution Services |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Nexgenia, Inc.
 Nexgenia, Inc. Medical SpecialtiesHealth Technology Develops stimuli-responsive polymers and polymer-containing magnetic nanoparticles | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Regence BlueShield
 Regence BlueShield Life/Health InsuranceFinance Provides health insurance services | Finance |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Invests in partnerships with local organizations that use market-based solutions for people living in poverty | Finance |
Inventprise LLC
Inventprise LLC Pharmaceuticals: MajorHealth Technology Manufactures vaccines | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Parker Bioconsulting |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
